The group's principal activity is to develop, manufacture and market pharmaceutical products. The group focuses on vaso active lipid encapsulated or vale, transdermal delivery technology drugs. Currently, we market athlete's relief and osteon in the United States. The group's products include analgesics, toenail fungal treatment, acne, first aid, hand and body lotion and psoriasis treatment. The group is planning to rebrand the defeet athlete's foot anti-fungal medication product as termin8 and xtinguish.
